A phase 1 study of Resunab in healthy volunteers

Trial Profile

A phase 1 study of Resunab in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 08 Nov 2017

At a glance

  • Drugs Ajulemic acid (Primary) ; Prednisolone
  • Indications Cystic fibrosis; Scleroderma
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
    • 28 Sep 2016 According to Corbus Pharmaceticals media release, data from this study was presented at 6th European Workshop on Lipid Mediators at Goethe University in, Germany.
    • 28 Sep 2016 Results were published in Corbus Pharmaceuticals Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top